🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Molly C. Holbrook

ORCID: 0000-0002-5491-9624

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions”.

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions

Cancers(2021)10.3390/cancers13051171

N/A

0DataRank · unranked

25 citations

Dakota W. Goad, Valery Z. Grdzelishvili, Molly C. Holbrook

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus

Molecular Therapy — Oncolytics(2021)10.1016/j.omto.2021.11.019

N/A

0DataRank · unranked

17 citations

Christian Bressy, Molly C. Holbrook, Valery Z. Grdzelishvili, Dakota W. Goad

Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virus

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201089

N/A

0DataRank · unranked

0 citations

Dakota W. Goad, Molly C. Holbrook, Quinton Krueger, Isha M. Wilson, M Abdul Hajjar +2 more